Organonitrogen Compounds
Cambridge Isotope Laboratories Tetramethylammonium deuteroxide 5D2O (D13 98%) 1 g
Tetramethylammonium deuteroxide 5D2O (D13 98%) 1 g
Medchemexpress LLC 1,6-Hexanediaminium, N1,N1,N1,N6,N6,N6-hexamethyl-, bromide (1:2) | 55-97-0 | 99.9% | 25 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) with mixed competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Exhibits mixed competitive and noncompetitive activity
- Attenuates sympathetic activity and blood pressure
- Targets apoptosis, cardiovascular disease, and neurological disease
- Appears as a white to off-white solid
Medchemexpress LLC Hexamethonium Bromide | 55-97-0 | MFCD00011787 | 50 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) that exhibits both competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Features both competitive and noncompetitive activity
- Exhibits anti-hypertensive activity
- Attenuates sympathetic activity and blood pressure in animal models
- Targeted towards nAChR and apoptosis
- Relevant for cardiovascular and neurological disease research
Medchemexpress LLC Hexamethonium Bromide | 55-97-0 | 99.91% | 5 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor (nAChR) antagonist, exhibiting both competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to reduce sympathetic activity and blood pressure in animal models of spontaneous hypertension.
- Non-selective ganglionic nicotinic-receptor antagonist
- Demonstrates mixed competitive and noncompetitive activity
- Exhibits anti-hypertensive activity
- Attenuates sympathetic activity
- Reduces blood pressure in spontaneously hypertensive animal models
Sigma Aldrich Fine Chemicals Biosciences Hexamethonium bromide | 55-97-0 | MFCD00011787 | 100G
Hexamethonium bromide | Mol Wt: 362.19 | 55-97-0 | MFCD00011787 | 100G
Medchemexpress LLC Hexamethonium bromide | 55-97-0 | MFCD00008323 | 99.9% | 1 G
Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor (nAChR) antagonist with mixed competitive and noncompetitive activity. It possesses anti-hypertensive activity and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.
- Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
- Mixed competitive and noncompetitive activity
- Anti-hypertensive activity
- Attenuates sympathetic activity and blood pressure in spontaneously hypertensive animal models
Apexbio Technology LLC Decamethonium Bromide 541-22-0 10g
Decamethonium Bromide (CAS 541-22-0) is a bis-quaternary ammonium compound targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction It is designed to bind and activate muscle-type nAChRs thereby inducing sustained depolarization and neuromuscular blockade Decamethonium Bromide exerts its biological activity primarily through partial agonist-mediated depolarization block of these receptors preventing normal muscle contractions Based on these pharmacological properties Decamethonium Bromide holds research potential in the evaluation of neuromuscular blockers and in studies elucidating receptor-channel function in neuromuscular transmission
Sigma Aldrich Fine Chemicals Biosciences Decamethonium bromide crystalline | 541-22-0 | MFCD00011779 | 25G
Decamethonium bromide crystalline | Mol Wt: 418.29 | 541-22-0 | MFCD00011779 | 25G